{"filing":{"accession_number":"0001493152-26-030044","cik":"0000855683","ticker":"MLSS","company_name":"MILESTONE SCIENTIFIC INC.","form":"8-K","filing_date":"2026-06-25","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/855683/000149315226030044/form8-k.htm"},"events":[{"id":13764,"run_id":12227,"accession_number":"0001493152-26-030044","anchor_item_number":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"The filing discloses multiple governance events: (1) appointment of two independent directors (Kelly Ulto and Greg Shilling) with significant expertise in audit, finance, and healthcare technology; (2) transition of Benedetta Casamento from Board Chair to Executive Chair with expanded strategic responsibilities; and (3) restructuring of Leonard Osser's role from Managing Director to Advisor with modified compensation. While Item 5.02 covers director appointments and executive compensation, the primary focus is the comprehensive governance restructuring and board strengthening, which is material to investors assessing leadership and oversight capabilities.","company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","filing_date":"2026-06-25","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":10996,"accession_number":"0001493152-26-030044","item_number":null,"item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses multiple governance events: (1) appointment of two independent directors (Kelly Ulto and Greg Shilling) with significant expertise in audit, finance, and healthcare technology; (2) transition of Benedetta Casamento from Board Chair to Executive Chair with expanded strategic responsibilities; and (3) restructuring of Leonard Osser's role from Managing Director to Advisor with modified compensation. While Item 5.02 covers director appointments and executive compensation, the primary focus is the comprehensive governance restructuring and board strengthening, which is material to investors assessing leadership and oversight capabilities.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T13:01:37.914476+00:00","company_name":"MILESTONE SCIENTIFIC INC.","ticker":"MLSS","filing_date":"2026-06-25"}]}